The Medtronic MiniMed™ 670G hybrid closed-loop (HCL) system was investigated in a multi-center pivotal trial conducted in 1T1D children aged 7-13 years. A 3-month at-home study phase with Auto Mode enabled followed the 2 week run-in phase in Manual Mode. The system improved overall glycemic control and minimized the percentage of time in hypoglycemia (≤70mg/dL, 3.9mmol/L). Several aspects of the postprandial response and sensor glucose (SG) values, during the run-in and study were compared. The maximum increase in SG (mg/dL) per 50 grams of carbohydrate (carb) in postprandial responses >3h; settling time, defined as the minutes for the postprandial response to settle back to <10mg/dL of the glycemic value at meal start; and the 3-h postprandial distribution of SG values were analyzed. Analyses were separated into 4-11am, 11am-4pm, and 4pm-4am periods. The median (IQR) for the postprandial maximum SG increase 4-11am was 91 (139) and 96 (136) mg/dL, p=0.34; for 11am-4pm was 86 (152) and 82 (141) mg/dL, p=0.66; and for 4pm-4am was 102(182) and 87.5 (166), p<0.001, for run-in and study, respectively. That for settling time for 4-11am was 192 (176) and 189 (158) min, p<0.001; for 11am-4am was 195.5 (213) and 191 (217) min, p=0.24; and for 4pm-4am was 295 (555) and 221 (447) min, p<0.001, respectively. That for 3-h postprandial SG values for 4-11am was 154 (106) and 150.5 (88) mg/dL, p=0.004; for 11am-4pm was 159.5 (104) and 153 (93) mg/dL, p<0.001; and for 4pm-4am was 163 (106) and 158 (89) mg/dL, p=0.001, respectively. The postprandial response in most of the tested outcomes between the study and run-in phase was significantly improved when the MiniMed™ 670G Auto Mode feature was enabled. For meals consumed between 4pm-4am, a reduction of 14.5 mg/dL was observed in the median maximum SG per 50 grams of carb. Furthermore, for meals consumed between 4pm-4am, settling time was reduced by 74 minutes. Overall, the HCL system reduced postprandial excursions and settling times throughout the day, while showing significant improvements 4pm-4am.

Disclosure

B. Grosman: Employee; Self; Medtronic. A. Roy: Employee; Self; Medtronic MiniMed, Inc.. D. Wu: None. N. Parikh: Employee; Self; Medtronic. S.W. Lee: Employee; Self; Medtronic. F.R. Kaufman: Employee; Self; Medtronic.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.